A recently published report describes the case of a 59-year-old male patient who experienced olmesartan-associated enteropathy (OAE) and highlights the importance of performing thorough medication reviews.
A great deal of progress has been made in reducing the burden of diarrheal diseases, but this reduction has not been equal globally.
The test works by measuring levels of anti-cytolethal distending toxin B (CdtB) and anti-vinculin, 2 biomarkers of post-infectious IBS-D and IBS-M.
A 2-week course of treatment with rifaximin for diarrhea-predominant irritable bowel syndrome was found to improve abdominal pain symptoms.
The first step for managing a patient with diarrhea is to determine the severity of dehydration according to the estimated volume loss and the symptoms and signs noted on physical examination.
A 60-year-old man with a history of gastroesophageal reflux disease presents to the emergency department with 2 to 3 days of fever, non-bloody diarrhea, and a worsening non-pruritic rash.
Supplements have no clear effect on mortality and a slight effect on promoting children’s growth.
Probiotic supplements do not appear to prevent antibiotic-associated diarrhea (AAD) or diarrhea caused by Clostridium difficile in elderly patients.
For patient’s with chemotherapy induced diarrhea, try alternating between these two medications before moving on to something stronger.
What are the next steps after ruling out Clostridium difficile?
